Notice for ChAdOx1-S [recombinant] (AstraZeneca Pty Ltd)
Active ingredients
ChAdOx1-S [recombinant]
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Indication
For the prevention of COVID-19
Therapeutic area
Infectious diseases